Front Page News

Meet the NDEAM Webinar Panelists

October 24, 2018
Posted in ,

October is National Disability Employment Awareness Month (NDEAM)! Hear directly from adults living with SMA in the workforce. Register for Cure SMA’s first NDEAM webinar. […]

Read More ›

Meet the National Disability Employment Awareness Month (NDEAM) Panelists

October 24, 2018
Posted in ,

October is National Disability Employment Awareness Month (NDEAM)! Hear directly from adults living with SMA in the workforce. Register for Cure SMA’s first NDEAM webinar. […]

Read More ›

NDEAM Spotlight: Jaclyn Greenwood

October 23, 2018
Posted in ,

The below guest blog post was written by Jaclyn Greenwood in honor of National Disability Employment Awareness Month. Jaclyn is a board certified genetic counselor […]

Read More ›

National Disability Employment Awareness Month Spotlight: Kim Hill

October 19, 2018
Posted in ,

The below NDEAM Spotlight was written by Kim Hill, Disability Integration Specialist at the Oklahoma Department of Emergency Management, who also lives with SMA Type […]

Read More ›

Register for Cure SMA’s First National Disability Employment Awareness Month Webinar

October 18, 2018
Posted in ,

October is National Disability Employment Awareness Month (NDEAM)! In its honor, Cure SMA is hosting our first NDEAM webinar where the audience will hear directly […]

Read More ›

AveXis Issues Community Statement on FDA Filing for SMA Type I

October 18, 2018
Posted in ,

AveXis has provided the following community statement on their FDA filing for SMA type I. Dear SMA Community, AveXis, a Novartis company, is pleased to […]

Read More ›

AveXis Files for FDA Approval of Gene Therapy for Spinal Muscular Atrophy
Type I

October 18, 2018
Posted in ,

AveXis, Inc., a Novartis company, today announced that they have filed for FDA approval of AVXS-101, a gene therapy that replaces the survival motor neuron […]

Read More ›

North Carolina to Screen Newborns for SMA Through Early Check

October 17, 2018
Posted in , ,

Early Check, a new research study led by RTI International, is now available for newborn babies in North Carolina. Early Check is a free screening […]

Read More ›

Breakthrough Prize Awarded to Adrian Krainer and Frank Bennett for SMA Research Leading to Spinraza

October 17, 2018
Posted in ,

Collaborators Adrian Krainer, of Cold Spring Harbor Laboratory, and C. Frank Bennett, from Ionis Pharmaceuticals, received the 2019 Breakthrough Prize in Life Sciences. They won […]

Read More ›

Cure SMA Receives Generous Funding from Luke 18:1 Foundation

October 10, 2018
Posted in , ,

Cure SMA would like to thank the Luke 18:1 Foundation for their generous donations to our equipment pool and research programs. The foundation’s generosity will […]

Read More ›
Scroll to Top